<DOC>
	<DOCNO>NCT02308267</DOCNO>
	<brief_summary>This project entitle `` Impaired secretory IgA mucosal immunity cystic fibrosis '' research program aim determine , owe national ( KULeuven ) international ( Descartes university Paris , university Torino ) collaboration expertise access human material , whether defect exists production IgA antibody lung patient serious genetic disease . These antibody line protect normally airway , secrete specific epithelial receptor call pIgR ( polymeric immunoglobulin receptor ) ; expression regulation study lung tissue cell culture lung epithelium patient . The link putative IgA defect chronic bacterial infection Pseudomonas aeruginosa , often complicate evolution disease , also evaluate ex vivo vivo , animal model lung infection .</brief_summary>
	<brief_title>Impaired Secretory IgA Mucosal Immunity Cystic Fibrosis</brief_title>
	<detailed_description>Impaired secretory IgA mucosal immunity cystic fibrosis : role CFTR-related epithelial change regulation pIgR-mediated IgA transcytosis contribution lung pathology impair defence bacterial infection . PROJECT DESCRIPTION Cystic fibrosis ( CF ) represent common lethal autosomal recessive disorder white population , mainly affect lung . Twenty-four year identification gene responsible disease , many question remain , current treatment symptomatic remains lethal disease . It affect Cystic Fibrosis Transmembrane Regulator ( CFTR ) gene , encode protein express apical membrane airway epithelial cell , act cAMP-dependent chloride channel regulator channel , include epithelial Na+ channel ( ENaC ) . Mutations CFTR ( F508del , 70 % case ) either result malfunction complete absence CFTR protein apical membrane , due protein misfolding retention endoplasmic reticulum . It result defect chloride efflux hydration epithelial lining fluid , result abnormally viscous mucus may obstruct airway , intestinal lumen glandular duct ( e.g . pancreas ) . CFTR dysfunction also lead pro-inflammatory activation ( e.g . NFkB ) epithelium , result CXCL8/IL8 release ( Sloane et al , 2005 ) impair production protective factor a-defensins . Airway colonization airway lung infection hallmark disease , particular Pseudomonas aeruginosa ( PA ) affect 70 % CF patient associate poor clinical outcome . However , mechanism underlie persistence pathogen CF airway , remain largely unclear . This project aim investigate whether production secretory IgA ( S-IgA ) impair CF lung , mechanism , whether defect contributes pathogenesis CF impair immunoprotection respiratory pathogen PA. S-IgA major line mucosal defense , so-called immune exclusion inhale / ingest antigen pathogen ( Norderhaug et al , 1999 ) . Following synthesis polymeric ( mainly dimeric ) IgA subepithelial mucosal plasma cell , p-IgA transport across epithelium transcellular rout mediate polymeric immunoglobulin receptor ( pIgR ) . P-IgA bind pIgR basolateral pole epithelium , transcytosed apical pole , proteolytic cleavage release extracellular part pIgR , call secretory component ( SC ) remain bound p-IgA form S-IgA . This transport represent important transcellular routing body ( 3g/day ) . S-IgA mainly produce upon mucosal stimulation microbial signal act Toll-like receptor epithelial cell B cell ( MacPherson et al , 2008 ) cytokine ( IFN-g , IL-4 , IL-1 TNF-a ) may upregulate pIgR expression and/or transcytosis ( see review Pilette et al , 2001a ) . A defect pIgR expression identify smoke-induced chronic obstructive pulmonary disease ( COPD ) ( Pilette et al , 2001b ) . Reduced pIgR COPD could due degradation neutrophil-derived serine proteinase ( Pilette et al , 2003 ) , well impaired gene transcription ( Gohy &amp; Pilette , submit manuscript ) . In contrast COPD , remain unclear whether pIgR expression affect CF , mechanism , , consequence term mucosal defense . Our hypothesis pIgR expression reduce CF epithelium , result CFTR-related epithelial change , lead impaired IgA-mediated immune exclusion respiratory pathogen , thereby favor chronic bacterial colonization lung infection CF . The specific objective project follow : 1. evaluate pIgR &amp; IgA expression bronchial tissue CF patient , compare control . This perform lung explants CF patient end-stage lung disease ( 11 KULeuven 18 Paris , already collect ; compare 7 explants control lung surgical specimen non-smokers ) bronchial biopsy ( n=8 ) BAL ( 2x50mL ) sample pre-transplantation bronchoscopies ( prospective sampling , KULeuven ) . Control subject patient without CF without evidence lung disease undergoing narcosis independent reason KULeuven centre . In addition , series sputum ( CF control patient ) also analyze . Control subject consist COPD patient healthy subject ( smoker ) . Moreover , nasosinusal rectal biopsy CF also obtain , order investigate mucosal CF tissue outside lung environment . Readouts consist pIgR expression gene ( RT-qPCR ) protein ( immunohistochemistry , western blot ) level , well IgA ( immunohistochemistry , RT-qPCR IgA1 IgA2 ) . In addition , ( S- ) IgA SC measure bronchial lavage fluid sputum . Globally , expect possible analyse 30 explants , 30 endoscopy 150 sputum . 2. evaluate S-IgA antibody respiratory bacteria CF airway : The relevance S-IgA deficiency CF assess regard microbial colonisation lower airway . First , correlation low S-IgA level ( total IgA pathogen-specific IgA ) colonisation pathogens - particular PA - test sputum bronchial lavage fluid CF patient . In addition , lung explants regional/spatial relationship S-IgA defect PA staining also address . Second , PA-specific IgA antibody assay bronchial lavage sputum fluid , correlate colonisation data . 3. evaluate contribution S-IgA defect lung pathology CFTR KO mouse : The potential contribution S-IgA deficiency CF lung disease assess vivo , use CFTR KO mouse . As KO mouse recapitulate human CF phenotype , take advantage pilot observation repeat LPS exposure - lead COPD-like phenotype ( Juanita et al , 2002 ) - result pIgR/SC downregulation ( see `` Results obtain '' ) . We thus evaluate whether pIgR deficiency induce upon chronic LPS exposure promote CFTR KO mouse development lung pathology CF feature . Accordingly , double ( CFTR , pIgR ) KO mouse could generate directly address contribution pIgR deficiency lung pathology conjunction CFTR mutation . In addition , second model mimic persistent PA infection ( Martin et al , 2011 ) use address effect PA CFTR and/or pIgR KO mouse . Beta-eNaC Tg mouse baseline lung pathology could also obtain infected model PA infection ( microbeads , Pr Burgel ) . Readouts include histomorphological biomolecular analysis ( inflammatory cytokine response ) , lung function test ( FlexiVent ) . 4. explore mechanisms pIgR downregulation CF epithelium : As CFBE 41o-cell line ( express wt mutant F508del CFTR ; Bruscia et al , 2002 ) express significant level pIgR ( see `` Results obtain '' ) , primary human bronchial epithelial cell ( HBEC ) use ass whether pIgR downregulation maintain CF epithelium culture vitro . Primary culture air-liquid interface ( ALI ) HBEC carry CF patient , compare control ( up-and-running protocol PI 's lab COPD ; cell EpithelixR also use ; well nasal cell CF ( de Courcey et al , 2012 ) ) . ALI culture allow evaluate cellular function polarize reconstitute muco-ciliary airway epithelium , either rest stimulate LPS and/or IL-1 . If pIgR expression also decrease CF epithelium vitro , could relate either CFTR gene defect and/or epigenetic memory vivo imprint epithelium inflammatory microenvironment . We thus distinguish possibility use CFTR inhibitor ( CFTR-inh172 , PPQ-102 ; Martin et al , 2013 ) . Another post-transcriptional mechanism pIgR dysfunction include wrong address cell membrane : relationship disturbed expression receptor ( apical CFTR , basal pIgR ) evaluate . Readouts include pIgR expression assess immunostaining ( filter ) western blot , RT-qPCR . The function pIgR test measure capacity ALI epithelium transcytose dimeric IgA basolateral apical compartment . Membrane address CFTR ( apical ) pIgR ( basal ) study confocal microscopy .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Immunoglobulin A , Secretory</mesh_term>
	<criteria>CF : adult CF patient ( age 18 ) classical clinical phenotype relate DF508/DF508 mutation , colonize Pseudomonas aeruginosa &lt; 18 year chronic lung disease except COPD specific control subgroup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>Mucosal immunity</keyword>
</DOC>